Admission Serum Iron as an Independent Risk Factor for Postoperative Delayed Cerebral Ischemia Following Aneurysmal Subarachnoid Hemorrhage: A Propensity-Matched Analysis.
delayed cerebral ischemia
hemoglobin
intracranial aneurysm
iron
stroke
subarachnoid hemorrhage
Journal
Brain sciences
ISSN: 2076-3425
Titre abrégé: Brain Sci
Pays: Switzerland
ID NLM: 101598646
Informations de publication
Date de publication:
02 Sep 2022
02 Sep 2022
Historique:
received:
31
07
2022
revised:
12
08
2022
accepted:
29
08
2022
entrez:
23
9
2022
pubmed:
24
9
2022
medline:
24
9
2022
Statut:
epublish
Résumé
This study aimed to investigate the association between serum iron (SI) and postoperative delayed cerebral ischemia (DCI) following aneurysmal subarachnoid hemorrhage (aSAH). We retrospectively analyzed 985 consecutive adult patients diagnosed with aSAH. Demographic, clinical, and laboratory data were recorded. Univariate and multivariate analyses were employed to assess the association between SI and DCI. Propensity-score matching (PSM) analysis was implemented to reduce confounding. Postoperative DCI developed in 14.38% of patients. Lower SI upon admission was detected in aSAH patients with severe clinical conditions and severe aSAH. SI was negatively correlated with WFNS grade (r = −0.3744, p < 0.001) and modified Fisher (mFisher) grade (r = −0.2520, p < 0.001). Multivariable analysis revealed lower SI was independently associated with DCI [odds ratios (OR) 0.281, 95% confidence interval (CI) 0.177−0.448, p < 0.001], while WFNS grade and mFisher grade were not. The receiver-operating characteristics (ROC) curve analysis of SI for DCI gave an area under the curve (AUC) of 0.7 and an optimal cut-off of 7.5 μmol/L (95% CI 0.665 to 0.733, p < 0.0001). PSM demonstrated the DCI group had a significantly lower SI than the non-DCI group (10.91 ± 6.86 vs. 20.34 ± 8.01 μmol/L, p < 0.001). Lower SI remained a significant independent predictor for DCI and an independent poor prognostic factor of aSAH in multivariate analysis (OR 0.363, 95% CI 0.209−0.630, p < 0.001). The predictive performance of SI for poor outcome had a corresponding AUC of 0.718 after PSM. Lower SI upon admission is significantly associated with WFNS grade, mFisher grade, and predicts postoperative DCI and poor outcome at 90 days following aSAH.
Identifiants
pubmed: 36138920
pii: brainsci12091183
doi: 10.3390/brainsci12091183
pmc: PMC9496804
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : National Natural Science Foundation of China
ID : 81870930
Organisme : National Natural Science Foundation of China
ID : 82171327
Organisme : Technology Platform Construction Project of Fujian Province
ID : 2021Y2001
Organisme : Technology Platform Construction Project of Fujian Province
ID : 2020Y2003
Commentaires et corrections
Type : ErratumIn
Références
Sci Rep. 2019 Apr 15;9(1):6054
pubmed: 30988354
Stroke. 2010 Jan;41(1):e47-52
pubmed: 19875741
J Neurosurg. 2017 Feb;126(2):504-510
pubmed: 26967776
Epilepsy Res. 2013 Dec;107(3):244-52
pubmed: 24128993
Stroke. 2013 Jan;44(1):43-54
pubmed: 23250997
Front Mol Neurosci. 2018 Mar 22;11:71
pubmed: 29623028
Stroke. 2018 Nov;49(11):2630-2636
pubmed: 30355184
Int J Mol Sci. 2021 Apr 16;22(8):
pubmed: 33923626
Lancet Neurol. 2009 May;8(5):427-33
pubmed: 19329361
J Neurointerv Surg. 2019 Nov;11(11):1135-1140
pubmed: 30979846
Br J Neurosurg. 2017 Aug;31(4):439-445
pubmed: 28335640
Stroke. 2010 Oct;41(10):2391-5
pubmed: 20798370
Int J Mol Sci. 2021 Aug 31;22(17):
pubmed: 34502401
Stroke. 2011 Apr;42(4):924-9
pubmed: 21311062
Nat Rev Neurol. 2014 Jan;10(1):44-58
pubmed: 24323051
J Neurointerv Surg. 2013 Nov;5(6):512-7
pubmed: 22952245
Eur J Intern Med. 2016 Jul;32:31-7
pubmed: 27113814
Stroke. 2018 Aug;49(8):1859-1865
pubmed: 29946013
JAMA Neurol. 2016 Jan;73(1):28-35
pubmed: 26552033
Stroke. 2010 Apr;41(4):810-3
pubmed: 20185788
Neurocrit Care. 2020 Apr;32(2):550-563
pubmed: 31346934
Case Rep Neurol Med. 2012;2012:487080
pubmed: 22937352
J Comp Pathol. 2019 Nov;173:58-70
pubmed: 31812174
J Pharmacol Exp Ther. 1996 May;277(2):1167-76
pubmed: 8627529
Neurocrit Care. 2014 Oct;21(2):285-93
pubmed: 24710655
Am J Nephrol. 2009;29(6):571-81
pubmed: 19136818
J Neurosurg. 2000 Mar;92(3):390-400
pubmed: 10701524
Brain. 2012 Jan;135(Pt 1):259-75
pubmed: 22120143
Front Neurol. 2021 Jun 03;12:671098
pubmed: 34149601
Neurocrit Care. 2019 Dec;31(3):466-475
pubmed: 31016639
Acta Neurol Belg. 2021 Oct;121(5):1311-1324
pubmed: 33423218
Curr Neurol Neurosci Rep. 2021 Jul 26;21(9):50
pubmed: 34308493
Nutr Hosp. 2005 Mar-Apr;20(2):115-20
pubmed: 15813395
J Clin Neurosci. 2020 Aug;78:108-113
pubmed: 32600972
Lancet Neurol. 2019 Nov;18(11):1058-1066
pubmed: 31296369
Neuromolecular Med. 2019 Sep;21(3):262-274
pubmed: 31134485
Neurol Res Int. 2013;2013:506584
pubmed: 24058736
J Cereb Blood Flow Metab. 2013 Jul;33(7):1008-14
pubmed: 23549379
Free Radic Res. 2008 Sep;42(9):824-9
pubmed: 19051108
Stroke. 2001 Sep;32(9):2012-20
pubmed: 11546890
World Neurosurg. 2019 Jun;126:e907-e913
pubmed: 30872197
Nat Rev Neurol. 2018 Jul;14(7):416-432
pubmed: 29925923
Neurocrit Care. 2022 Feb;36(1):171-179
pubmed: 34374002
Neurocrit Care. 2020 Dec;33(3):749-758
pubmed: 32246437
Lancet. 2017 Feb 11;389(10069):655-666
pubmed: 27637674
Lancet Neurol. 2006 Jan;5(1):53-63
pubmed: 16361023
J Am Heart Assoc. 2021 Aug 3;10(15):e021845
pubmed: 34325514
J Cereb Blood Flow Metab. 2010 Nov;30(11):1791-2
pubmed: 20736954
J Cereb Blood Flow Metab. 2010 Nov;30(11):1793-803
pubmed: 20736956
J Neuroinflammation. 2019 Nov 11;16(1):213
pubmed: 31711504
JAMA Neurol. 2017 Sep 1;74(9):1081-1087
pubmed: 28715558
N Engl J Med. 2017 Jul 20;377(3):257-266
pubmed: 28723321
Neurocrit Care. 2010 Jun;12(3):342-5
pubmed: 20069390
Nutrients. 2013 Jul 01;5(7):2384-404
pubmed: 23857219
J Atheroscler Thromb. 2013;20(8):670-7
pubmed: 23615377
Proc Natl Acad Sci U S A. 2015 Jan 27;112(4):1155-60
pubmed: 25583472
Curr Neurovasc Res. 2014;11(3):248-53
pubmed: 24875488